HSPB1 and metabolic dysfunction-associated steatotic liver disease: To better understand how human HSPB1 influences the progression of MetS, we further investigated the underlying mechanisms of obesity-related complications, including inflammation, NAFLD, and impaired cardiac function and morphology.